Transfection of mouse bone marrow mesenchymal stem cells with lipofectamine-mediated Cytosine deaminase genes

Journal of Clinical Rehabilitative Tissue Engineering Research

Volumn 13, Issue 49, 2009, Pages 9775-9778

  Song, Fei ^a,b   Xing, Qi ^b   Ji, Guang Chun ^b   Ma, Yu Fang ^b   Ma, Xue Hu ^a  

^a DALIAN UNIVERSITY OF TECHNOLOGY   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; CYTOSINE DEAMINASE; ENDOGLIN; GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN 1; HERMES ANTIGEN; LIPOFECTAMINE; LIPOSOME; THY 1 ANTIGEN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR IRES2; UNCLASSIFIED DRUG;

AGAR GEL ELECTROPHORESIS; ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL ADHESION; CELL CULTURE; CELL STRUCTURE; CONTROLLED STUDY; CYTOLOGY; ESCHERICHIA COLI; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENETIC TRANSFECTION; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; RECOMBINANT PLASMID;

ESCHERICHIA COLI; EUKARYOTA; MUS;

EID: 77953750808     PISSN: 16738225     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1673-8225.2009.49.037     Document Type: Article

References (20)

1. Kraitchman DL, Tatsumi M, Gilson WD, et al. Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation. 2005;112(10):1451-1461.
2. Schrepfer S, Deuse T, Lange C, et al. Simplified protocol to isolate, purify, and culture expand mesenchymal stem cells. Stem Cells Dev. 2007;16(1):105-107.
3. Uccelli A, Moretta L, Pistoia V. Immunoregulatory function of mesenchymal stem cells. Eur J Immunol. 2006;36(10):2566-2573. (Pubitemid 44608440)
4. Ramasamy R, Fazekasova H, Lam EW, et al. Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation. 2007;83(1):71-76.
5. Beyth S, Borovsky Z, Mevorach D, et al. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood. 2005;105(5):2214-2219.
6. Kim JA, Hong S, Lee B, et al. The inhibition of T-cells proliferation by mouse mesenchymal stem cells through the induction of p16INK4A-cyclin D1/cdk4 and p21waf1, p27kip1-cyclin E/cdk2 pathways. Cell Immunol. 2007;245(1):16-23.
7. Studeny M, Marini FC, Dembinski JL, et al. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst. 2004;96(21):1593-1603.
8. Djouad F, Plence P, Bony C, et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood. 2003;102(10):3837-3844.
9. Pedroso de Lima MC, Neves S, Filipe A, et al. Cationic liposomes for gene delivery: from biophysics to biological applications. Curr Med Chem. 2003;10(14):1221-1231.
10. Rainov NG, Ren H. Gene therapy for human malignant brain tumors. Cancer J. 2003;9(3):180-188.
11. Zheng AQ, Song XR, Yu JM, et al. Liposome transfected to plasmid-encoding endostatin gene combined with radiotherapy inhibits liver cancer growth in nude mice. World J Gastroenterol. 2005;11(28):4439-4442.
12. The Ministry of Science and Technology of the People's Republic of China. Guidance Suggestions for the Care and Use of Laboratory Animals. 2006-09-30.
13. Miyagi T, Koshida K, Hori O, et al. Gene therapy for prostate cancer using the cytosine deaminase/uracil phosphoribosyltransferase suicide system. J Gene Med. 2003;5(1):30-37.
14. Kato H, Koshida K, Yokoyama K, et al. Potential benefits of combining cytosine deaminase/5-fluorocytosine gene therapy and irradiation for prostate cancer: experimental study. Int J Urol. 2002;9(10):567-576.
15. Denny WA, Prodrug strategies in cancer therapy. Eur J Med Chem. 2001;36(7-8): 577-595.
16. Mesnil M, Yamasaki H. Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication. Cancer Res. 2000;60(15):3989-3999.
17. Dilber MS, Abedi MR, Christensson B, et al. Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo. Cancer Res. 1997;57(8):1523-1528.
18. Nielsen CS, Moorman DW, Levy J P, et al. Herpes simplex thymidine kinase gene transfer is required for complete regression of murine colon adenocarcinoma. Am Surg. 1997;63(7):617-620.
19. Ram Z, Walbridge S, Shawker T, et al. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats. J Neurosurg. 1994;81(2):256-260.
20. Conticello SG, Thomas CJ, Petersen-Mahrt SK, et al. Evolution of the AID/APOBEC family of polynucleotide (deoxy) cytidine deaminases. Mol Biol Evol. 2005;22(2):367-377.